AFP and hepatocellular carcinoma: To date, only a handful of metabolomics studies in HCC have been reported, including the study from Lewinska et al. demonstrating that a panel of serum metabolites outperformed AFP in distinguishing patients with MASLD-HCC from those without HCC.40